NCM
FBIO icon

Nantahala Capital Management’s Fortress Biotech FBIO Stock Holding History

Nantahala Capital Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-325,520
Closed -$605K – 160
2025
Q2 		$605K Hold
325,520
– – 0.02% 145
2025
Q1 		$508K Buy
325,520
+200,000
+159% +$353K 0.02% 132
2024
Q4 		$254K Sell
125,520
-27,632
-18% -$50.1K 0.01% 131
2024
Q3 		$221K Hold
153,152
– – 0.01% 129
2024
Q2 		$262K Sell
153,152
-125,000
-45% -$227K 0.02% 120
2024
Q1 		$556K Sell
278,152
-94,410
-25% -$188K 0.03% 107
2023
Q4 		$1.12M Sell
372,562
-28,652
-7% -$75.8K 0.07% 105
2023
Q3 		$1.75M Sell
401,214
-24,833
-6% -$170K 0.15% 92
2023
Q2 		$3.51M Sell
426,047
-35,145
-8% -$348K 0.34% 61
2023
Q1 		$5.67M Sell
461,192
-70,012
-13% -$834K 0.43% 46
2022
Q4 		$5.22M Sell
531,204
-19,666
-4% -$218K 0.34% 49
2022
Q3 		$7.11M Sell
550,870
-33,040
-6% -$495K 0.46% 48
2022
Q2 		$7.36M Sell
583,910
-5,592
-0.9% -$82.9K 0.37% 52
2022
Q1 		$12M Sell
589,502
-16,232
-3% -$444K 0.53% 39
2021
Q4 		$22.7M Buy
605,734
+63,014
+12% +$2.81M 0.8% 35
2021
Q3 		$26.2M Buy
542,720
+40,775
+8% +$1.99M 0.83% 32
2021
Q2 		$26.9M Sell
501,945
-71,568
-12% -$4.32M 0.76% 30
2021
Q1 		$30.4M Sell
573,513
-5,214
-0.9% -$294K 0.89% 29
2020
Q4 		$27.5M Buy
578,727
+30,398
+6% +$1.32M 0.85% 29
2020
Q3 		$33.2M Buy
548,329
+253,333
+86% +$12.9M 1.02% 23
2020
Q2 		$11.9M Buy
294,996
+173,076
+142% +$6.43M 0.36% 58
2020
Q1 		$3.46M Buy
121,920
+94,773
+349% +$3.15M 0.13% 82
2019
Q4 		$1.05M Buy
27,147
+4,706
+21% +$121K 0.03% 84
2019
Q3 		$475K Buy
+22,441
New +$528K 0.02% 92
2014
Q2 		– Sell
-58,181
Closed -$1.73M – 98
2014
Q1 		$1.73M Hold
58,181
– – 0.28% 76
2013
Q4 		$2.29M Buy
+58,181
New +$2.25M 0.37% 66

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Nantahala Capital Management's FBIO Position: Q3 2025 in Review

Nantahala Capital Management sold out of Fortress Biotech (FBIO) in Q3 2025, closing a stake of 325,520 shares — an estimated $605K sold.

Nantahala Capital Management first reported a position in FBIO in Q4 2013 and held it in 26 quarters. The position peaked at $33.2M in Q3 2020. 56 funds tracked by Wall St. Rank hold FBIO as of Q3 2025.

  • Nantahala Capital Management reported no remaining Fortress Biotech position as of Q3 2025 after selling out during the quarter.
  • Nantahala Capital Management sold 325,520 Fortress Biotech shares in Q3 2025, an estimated $605K.
  • Nantahala Capital Management first reported a position in Fortress Biotech in Q4 2013 and held it in 26 quarters.
  • Nantahala Capital Management's Fortress Biotech position peaked at $33.2M in Q3 2020.
  • 56 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2025.

Based on Nantahala Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.